Noctrix Health
Latest round
- Series C
Last raised
- Jan 2024
Total raised
- $57M
Investors
- 7
About Noctrix Health
Founded in 2018 by Jonathan Charlesworth and Shriram Raghunathan, and based in California, US, Noctrix Health, Inc. operates as the developer and manufacturer of a wearable therapeutic device used for the management and treatment of Restless Legs Syndrome (RLS). In August 2025, Noctrix Health, Inc. Noctrix Health offers wearable therapeutic devices designed as alternatives to pharmaceuticals for managing chronic neurological conditions, like the Restless Legs Syndrome (RLS). The company's technology, known as Tonic Motor Activation (TOMAC), has received FDA marketing authorization and Breakthrough Device Designation.
Who invested in Noctrix Health
7 investors across 2 rounds
See all investors in Noctrix Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Noctrix Health
Who invested in Noctrix Health?
Noctrix Health has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Noctrix Health raised?
Noctrix Health has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Noctrix Health last raise money?
Noctrix Health's most recent round on record is a Series C, in Jan 2024.
What does Noctrix Health do?
Founded in 2018 by Jonathan Charlesworth and Shriram Raghunathan, and based in California, US, Noctrix Health, Inc.
Where is Noctrix Health headquartered?
Noctrix Health is headquartered in Pleasanton, US.
Which VCs invest in companies like Noctrix Health?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Noctrix Health's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Noctrix Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.